For example, administration of exogenous IL‐10 or IL‐10 inhibitor(s) have been shown to mitigate, or exacerbate AKI, respectively (Akai et al., 2019; Andres‐Hernando et al., 2017; Soranno et al., 2016; Tadagavadi & Reeves, 2010). This evidence concerns the gene IL10 and acute kidney injury.